Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...
Ergebnis 12 von 134
Molecular therapy. Methods & clinical development, 2024-09, Vol.32 (3), p.101294, Article 101294
2024
Volltextzugriff (PDF)

Details

Autor(en) / Beteiligte
Titel
The longitudinal kinetics of AAV5 vector integration profiles and evaluation of clonal expansion in mice
Ist Teil von
  • Molecular therapy. Methods & clinical development, 2024-09, Vol.32 (3), p.101294, Article 101294
Ort / Verlag
United States: Elsevier Inc
Erscheinungsjahr
2024
Quelle
EZB Electronic Journals Library
Beschreibungen/Notizen
  • Adeno-associated virus (AAV)-based vectors are used clinically for gene transfer and persist as extrachromosomal episomes. A small fraction of vector genomes integrate into the host genome, but the theoretical risk of tumorigenesis depends on vector regulatory features. A mouse model was used to investigate integration profiles of an AAV serotype 5 (AAV5) vector produced using Sf and HEK293 cells that mimic key features of valoctocogene roxaparvovec (AAV5-hFVIII-SQ), a gene therapy for severe hemophilia A. The majority (95%) of vector genome reads were derived from episomes, and mean (± standard deviation) integration frequency was 2.70 ± 1.26 and 1.79 ± 0.86 integrations per 1,000 cells for Sf- and HEK293-produced vector. Longitudinal integration analysis suggested integrations occur primarily within 1 week, at low frequency, and their abundance was stable over time. Integration profiles were polyclonal and randomly distributed. No major differences in integration profiles were observed for either vector production platform, and no integrations were associated with clonal expansion. Integrations were enriched near transcription start sites of genes highly expressed in the liver (p = 1 × 10−4) and less enriched for genes of lower expression. We found no evidence of tumorigenesis or fibrosis caused by the vector integrations. [Display omitted] Ismail and colleagues assessed the safety of an AAV5 vector-based gene therapy for >1 year in mice. They found AAV5 vectors have low integration rates in liver, with most integrations detected by ≤2 sequence reads. The integrations were polyclonal in nature, and no evidence of clonal expansion was observed.
Sprache
Englisch
Identifikatoren
ISSN: 2329-0501
eISSN: 2329-0501
DOI: 10.1016/j.omtm.2024.101294
Titel-ID: cdi_doaj_primary_oai_doaj_org_article_f3538b44edb3453095b5db1c549aaa71

Weiterführende Literatur

Empfehlungen zum selben Thema automatisch vorgeschlagen von bX